{
  "id": 1662411,
  "title": "Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposure",
  "url": "https://urgent.news/2026/08/18/leo-pharma-to-license-tanabes-rare-disease-drug-for-pain-with-sun",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-18T07:00:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/leo-pharma-to-license-tanabes-rare-disease-drug-for-pain-with-sun-exposure/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Leo Pharma said it will pay Japan’s Tanabe Pharma up to $435 million in upfront and near-term payments to license an oral drug for a pair of genetic light-sensitive skin diseases. The Danish biotech will ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}